(Total Views: 145)
Posted On: 09/20/2022 11:50:48 AM
Post# of 35809

$LXRX News Article - Lexicon Pharmaceuticals Highlights Scientific and Medical Presentations Relating to Its Successful Phase 2 Proof-Of-Concept Study of LX9211 in Painful Diabetic Neuropathy https://marketwirenews.com/news-releases/lexi...53861.html


My Twitter: WhyteStocks